Maravai Lifesciences Holdings Inc (MRVI) — Capital Reinvestment Ratio
Maravai Lifesciences Holdings Inc (MRVI) has a Capital Reinvestment Ratio of 0.09x as of June 2026, meaning it reinvests 0% of its operating cash flow ($3.99 Million) in capital expenditures ($370.00K). Check Maravai Lifesciences Holdings Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Maravai Lifesciences Holdings Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Maravai Lifesciences Holdings Inc's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see MRVI operating cash flow.
Annual Capital Reinvestment Ratio for Maravai Lifesciences Holdings Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Maravai Lifesciences Holdings Inc from 2019 to 2024. See how much free cash does Maravai Lifesciences Holdings Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.97x | $7.46 Million | $29.66 Million | ▲ +665.0% |
| 2023 | 0.52x | $126.22 Million | $65.55 Million | ▲ +1528.8% |
| 2022 | 0.03x | $535.98 Million | $17.09 Million | ▼ -20.9% |
| 2021 | 0.04x | $368.57 Million | $14.85 Million | ▼ -75.9% |
| 2020 | 0.17x | $152.19 Million | $25.41 Million | ▼ -76.5% |
| 2019 | 0.71x | $24.11 Million | $17.15 Million | — |